InnoCare Pharma Ltd.(INCPF)
$1.27-0.06 (-4.53%)
INCPF
InnoCare Pharma Ltd. financials statements
$1.27
At close:-0.06 (-4.53%)
InnoCare Pharma Ltd. (INCPF) Ratios
2 Followers
InnoCare Pharma Ltd. Ratios
INCPF's free cash flow for Q3 2026 was ¥76.65M. For the 2026 fiscal year, INCPF's free cash flow was decreased by ¥-61.50M and operating cash flow was ¥138.14M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.83 | 7.37 | 4.19 | 4.48 | 19.49 |
| Quick Ratio | 5.71 | 7.28 | 4.13 | 4.45 | 19.46 |
| Cash Ratio | 5.11 | 5.86 | 3.93 | 4.19 | 18.00 |
| Solvency Ratio | 0.24 | -0.14 | -0.20 | -0.31 | -0.02 |
| Operating Cash Flow Ratio | 0.14 | -0.34 | -0.32 | -0.27 | 0.51 |
| Short-Term Operating Cash Flow Coverage | 0.69 | -1.89 | -0.54 | -0.47 | 0.00 |
| Net Current Asset Value | ¥ 4.99B | ¥ 5.16B | ¥ 6.03B | ¥ 6.62B | ¥ 4.68B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.14 | 0.14 | 0.12 | 0.17 |
| Debt-to-Equity Ratio | 0.21 | 0.19 | 0.19 | 0.16 | 0.23 |
| Debt-to-Capital Ratio | 0.17 | 0.16 | 0.16 | 0.14 | 0.18 |
| Long-Term Debt-to-Capital Ratio | 0.14 | 0.13 | 0.00 | 0.04 | 0.18 |
| Financial Leverage Ratio | 1.40 | 1.40 | 1.39 | 1.36 | 1.32 |
| Debt Service Coverage Ratio | 1.59 | -2.04 | -0.40 | -0.65 | -11.48 |
| Interest Coverage Ratio | 8.21 | -15.56 | -18.59 | -45.20 | -68.55 |
| Debt to Market Cap | 0.08 | 0.12 | 0.12 | 0.08 | 0.07 |
| Interest Debt Per Share | 0.95 | 0.77 | 0.81 | 0.86 | 0.93 |
| Net Debt to EBITDA | -9.83 | 10.68 | 13.31 | 9.21 | -287.11 |
| Profitability Margins | |||||
| Gross Profit Margin | 87.59% | 86.29% | 82.61% | 77.07% | 93.70% |
| EBIT Margin | 19.18% | -51.66% | -82.48% | -140.18% | -1.68% |
| EBITDA Margin | 24.20% | -45.91% | -69.94% | -129.24% | 1.56% |
| Operating Profit Margin | 19.18% | -52.09% | -88.17% | -123.19% | -17.36% |
| Pretax Profit Margin | 27.80% | -44.84% | -87.23% | -142.90% | -1.93% |
| Net Profit Margin | 27.24% | -43.65% | -85.47% | -141.76% | -6.19% |
| Continuous Operations Profit Margin | 27.31% | -44.86% | -87.42% | -142.90% | -6.39% |
| Net Income Per EBT | 97.98% | 97.36% | 97.99% | 99.20% | 320.78% |
| EBT Per EBIT | 144.98% | 86.08% | 98.93% | 116.01% | 11.11% |
| Return on Assets (ROA) | 5.78% | -4.68% | -6.36% | -8.59% | -0.87% |
| Return on Equity (ROE) | 8.10% | -6.55% | -8.83% | -11.67% | -1.15% |
| Return on Capital Employed (ROCE) | 4.67% | -6.30% | -8.32% | -9.34% | -2.56% |
| Return on Invested Capital (ROIC) | 4.43% | -6.13% | -7.16% | -7.94% | -2.55% |
| Return on Tangible Assets | 5.92% | -4.70% | -6.39% | -8.63% | -0.89% |
| Earnings Yield | 3.21% | -4.53% | -5.93% | -4.98% | -0.38% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.53 | 2.88 | 4587186.34 | 3.52 | 11.57 |
| Payables Turnover | 1.55 | 1.08 | 0.95 | 1.21 | 0.78 |
| Inventory Turnover | 1.75 | 1.45 | 1.08 | 2.20 | 6.62 |
| Fixed Asset Turnover | 2.94 | 0.95 | 0.68 | 0.66 | 2.08 |
| Asset Turnover | 0.21 | 0.11 | 0.07 | 0.06 | 0.14 |
| Working Capital Turnover Ratio | 0.34 | 0.15 | 0.11 | 0.09 | 0.21 |
| Cash Conversion Cycle | 53.94 | 40.48 | -44.93 | -32.03 | -383.56 |
| Days of Sales Outstanding | 80.61 | 126.92 | 0.00 | 103.57 | 31.56 |
| Days of Inventory Outstanding | 208.55 | 251.99 | 338.46 | 166.27 | 55.13 |
| Days of Payables Outstanding | 235.22 | 338.43 | 383.39 | 301.87 | 470.25 |
| Operating Cycle | 289.16 | 378.91 | 338.46 | 269.84 | 86.69 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.11 | -0.22 | -0.39 | -0.38 | 0.12 |
| Free Cash Flow Per Share | 0.07 | -0.26 | -0.54 | -0.63 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 1.97 | -0.83 | -2.62 | -1.51 | 1.00 |
| Capital Expenditure Coverage Ratio | 2.91 | -4.67 | -2.64 | -1.53 | 1.00 |
| Operating Cash Flow Coverage Ratio | 0.12 | -0.29 | -0.50 | -0.45 | 0.13 |
| Operating Cash Flow to Sales Ratio | 0.09 | -0.36 | -0.91 | -0.90 | 0.16 |
| Free Cash Flow Yield | 0.67% | -4.57% | -8.69% | -5.25% | -0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 30.69 | -22.11 | -16.87 | -20.10 | -263.75 |
| Price-to-Sales (P/S) Ratio | 8.47 | 9.63 | 14.42 | 28.49 | 16.32 |
| Price-to-Book (P/B) Ratio | 2.52 | 1.45 | 1.49 | 2.35 | 3.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 148.84 | -21.90 | -11.50 | -19.04 | -1547640.84 |
| Price-to-Operating Cash Flow Ratio | 97.76 | -26.59 | -15.87 | -31.51 | 101.91 |
| Price-to-Earnings Growth (PEG) Ratio | -0.13 | 0.74 | 0.44 | -0.02 | 2.99 |
| Enterprise Value Multiple | 25.19 | -10.29 | -7.31 | -12.84 | 761.69 |
| Enterprise Value | 14.00B | 4.77B | 3.78B | 10.37B | 12.36B |
| EV to EBITDA | 25.19 | -10.29 | -7.31 | -12.84 | 761.69 |
| EV to Sales | 6.10 | 4.72 | 5.11 | 16.59 | 11.85 |
| EV to Free Cash Flow | 107.07 | -10.74 | -4.08 | -11.09 | -1123970.48 |
| EV to Operating Cash Flow | 70.32 | -13.04 | -5.62 | -18.34 | 74.01 |
| Tangible Book Value Per Share | 4.26 | 3.97 | 4.18 | 5.14 | 4.04 |
| Shareholders’ Equity Per Share | 4.39 | 3.98 | 4.19 | 5.13 | 4.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | -0.00 | -0.00 | 0.02 | -2.31 |
| Revenue Per Share | 1.30 | 0.60 | 0.43 | 0.42 | 0.76 |
| Net Income Per Share | 0.36 | -0.26 | -0.37 | -0.60 | -0.05 |
| Tax Burden | 0.98 | 0.97 | 0.98 | 0.99 | 3.21 |
| Interest Burden | 1.45 | 0.87 | 1.06 | 1.02 | 1.15 |
| Research & Development to Revenue | 0.37 | 0.81 | 1.02 | 1.02 | 0.69 |
| SG&A to Revenue | 0.33 | 0.31 | 0.07 | 0.08 | 0.04 |
| Stock-Based Compensation to Revenue | 0.03 | -0.01 | 0.09 | 0.21 | 0.12 |
| Income Quality | 0.32 | 0.81 | 1.04 | 0.63 | -8.30 |
Currency in CNY

